Could a simple pill replace IVs for migraines in the ER?
NCT ID NCT06985342
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at two FDA-approved migraine medications (a dissolving tablet and a nasal spray) given to adults in the emergency department. The goal was to see if these easy-to-use options could relieve pain quickly and shorten ER visits. The study was stopped early with only 9 participants, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE HEADACHES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.